We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Anna MacDonald

Anna MacDonald profile page

Senior Science Editor

 at Technology Networks


After obtaining a first-class honors degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.


Education


University of East Anglia  


Areas of Expertise



Got a Question for Anna MacDonald?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 323
The Impact of Industry and Technology on the Next Generation of Scientists content piece image
Listicle

The Impact of Industry and Technology on the Next Generation of Scientists

In this listicle, we summarize the findings from the "Science Futures" project and highlight three areas in which industry and technology are impacting the next generation of scientists.
A One-Stop Platform To Drive Progress in Gene Therapy Development content piece image
Industry Insight

A One-Stop Platform To Drive Progress in Gene Therapy Development

In this interview, Dr. Ren discusses some of the challenges that currently exist when developing gene therapies and explores how Cyagen’s one-stop gene therapy platform can help to address them.
Gene-Edited Stem Cell-Derived Therapies – A Functional Cure for T1D? content piece image
Industry Insight

Gene-Edited Stem Cell-Derived Therapies – A Functional Cure for T1D?

Technology Networks spoke with Michael Yang, president and chief executive officer of ViaCyte, to learn more about the development of a stem cell-derived therapy for the treatment of T1D and the technology behind it.
Metabolomics-Based Blood Test Could Enable Earlier Detection of Cancer content piece image
Article

Metabolomics-Based Blood Test Could Enable Earlier Detection of Cancer

Dr. James Larkin discusses the benefits of biofluid metabolomics and how an NMR-based approach could help to improve the way that cancer is detected and monitored in patients with nonspecific symptoms.
How Do Spreadsheets Hold Back Pharma Innovation? content piece image
Industry Insight

How Do Spreadsheets Hold Back Pharma Innovation?

Technology Networks spoke to Jesse Harris to learn why spreadsheets can be a bottleneck for pharma research and explore how they compare to laboratory informatics tools.
Building Expertise in Ion Chromatography content piece image
Industry Insight

Building Expertise in Ion Chromatography

In this interview, Gemma Ellison tells us more about the Ion Chromatography Education Hub, the range of content that it offers, and the benefits it provides IC users, whether they are new to the technique or have several years of experience.

PFAS Strategic Roadmap: Highlights and Expected Impacts content piece image
Industry Insight

PFAS Strategic Roadmap: Highlights and Expected Impacts

In this interview, Dr. Craig Butt discusses some of the highlights from the Roadmap and its expected impacts.
Agilent Science Futures – An Interview With Joyce O’Grady content piece image
Industry Insight

Agilent Science Futures – An Interview With Joyce O’Grady

In this interview, Joyce explains the impact her work could have on society, tells us about the benefits that open-source technology has had on her research and highlights the importance of researcher support programs.
Addressing the Challenges of AAV Production content piece image
Industry Insight

Addressing the Challenges of AAV Production

Technology Networks spoke to Emily Jackson-Holmes to learn more about the benefits of AAV vectors and reasons for the growing interest in their use.
A New Approach to Treating “Superbugs” content piece image
Article

A New Approach to Treating “Superbugs”

Technology Networks had the pleasure of speaking to Justin Schaal to learn more about MTD12813, its mode of action and how it addresses some of the shortcomings of traditional antibiotics.
Advertisement